The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with clonazepam.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with promethazine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Melatonin.


The risk or severity of adverse effects can be increased when procyclidine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with pentoxifylline.


The risk or severity of adverse effects can be increased when loxapine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when losartan is combined with indapamide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Iloperidone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with meclizine.


The risk or severity of adverse effects can be increased when quetiapine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Etomidate.


The risk or severity of adverse effects can be increased when maprotiline is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Normethadone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with losartan.


The risk or severity of adverse effects can be increased when Vecuronium is combined with hydromorphone.


The risk or severity of adverse effects can be increased when ramipril is combined with fosinopril.


The risk or severity of adverse effects can be increased when nalbuphine is combined with felbamate.


The risk or severity of adverse effects can be increased when Salsalate is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when metolazone is combined with Bretylium.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with flumethasone.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with tetracaine.


The risk or severity of adverse effects can be increased when benztropine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Drospirenone.


The risk or severity of adverse effects can be increased when clozapine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with cinoxacin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with felbamate.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when indomethacin is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Perampanel is combined with paroxetine.


The risk or severity of adverse effects can be increased when indomethacin is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when buspirone is combined with periciazine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with atorvastatin.


The risk or severity of adverse effects can be increased when dapsone is combined with celecoxib.


The risk or severity of adverse effects can be increased when mesalamine is combined with diflorasone.


The risk or severity of adverse effects can be increased when paroxetine is combined with selegiline.


The risk or severity of adverse effects can be increased when propofol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with fenoprofen.


The risk or severity of adverse effects can be increased when alclofenac is combined with alclometasone.


The risk or severity of adverse effects can be increased when decamethonium is combined with nicotine.


The risk or severity of adverse effects can be increased when decamethonium is combined with Cevimeline.


The risk or severity of adverse effects can be increased when halothane is combined with clidinium.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when bromazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when halothane is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when haloperidol is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when sulconazole is combined with isradipine.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with clonidine.


The risk or severity of adverse effects can be increased when barnidipine is combined with benazepril.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with diflorasone.


The risk or severity of adverse effects can be increased when Trospium is combined with butorphanol.


The risk or severity of adverse effects can be increased when halothane is combined with sotalol.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with mefloquine.


The risk or severity of adverse effects can be increased when isradipine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when meperidine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when butabarbital is combined with Ramelteon.


The risk or severity of adverse effects can be increased when estazolam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when estazolam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with medrysone.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when dyclonine is combined with sertraline.


The risk or severity of adverse effects can be increased when Tavaborole is combined with felodipine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with maprotiline.


The risk or severity of adverse effects can be increased when diazepam is combined with glutethimide.


The risk or severity of adverse effects can be increased when clomipramine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Escitalopram is combined with loxapine.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with Ximelagatran.


The risk or severity of adverse effects can be increased when Pipamperone is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Difenoxin.


The risk or severity of adverse effects can be increased when dibucaine is combined with zotepine.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with rescinnamine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when benzocaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when benzocaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with thiamylal.


The risk or severity of adverse effects can be increased when Phenelzine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with halothane.


The risk or severity of adverse effects can be increased when propofol is combined with Fospropofol.


The risk or severity of adverse effects can be increased when tenoxicam is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with alclofenac.


The risk or severity of adverse effects can be increased when meperidine is combined with Butethal.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with butalbital.


The risk or severity of adverse effects can be increased when clorazepate is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with carprofen.


The risk or severity of adverse effects can be increased when nimodipine is combined with terazosin.


The risk or severity of adverse effects can be increased when clorazepate is combined with fludiazepam.


The risk or severity of adverse effects can be increased when doxazosin is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with phenytoin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when sotalol is combined with furosemide.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when pentobarbital is combined with thioridazine.


The risk or severity of adverse effects can be increased when Lofexidine is combined with propofol.


The risk or severity of adverse effects can be increased when pentazocine is combined with amisulpride.


The risk or severity of adverse effects can be increased when benazepril is combined with indomethacin.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when clidinium is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with acebutolol.


The risk or severity of adverse effects can be increased when baclofen is combined with primidone.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when methysergide is combined with Palbociclib.


The risk or severity of adverse effects can be increased when propranolol is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Etidocaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with clonazepam.


The risk or severity of adverse effects can be increased when nitric oxide is combined with doxazosin.


The risk or severity of adverse effects can be increased when nitric oxide is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when phentolamine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with labetalol.


The risk or severity of adverse effects can be increased when Temsirolimus is combined with atorvastatin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Melatonin.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Tramadol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with enalapril.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with primidone.


The risk or severity of adverse effects can be increased when Tramadol is combined with scopolamine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when captopril is combined with indomethacin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with rasagiline.


The risk or severity of adverse effects can be increased when streptozocin is combined with leflunomide.


The risk or severity of adverse effects can be increased when nefazodone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when mechlorethamine is combined with leflunomide.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with zonisamide.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with edrophonium.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when Butethal is combined with Articaine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when procaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when procaine is combined with zotepine.


The risk or severity of adverse effects can be increased when clozapine is combined with levorphanol.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when morphine is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when diethylstilbestrol is combined with Ospemifene.


The risk or severity of adverse effects can be increased when amobarbital is combined with procaine.


The risk or severity of adverse effects can be increased when benzocaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when amiodarone is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when indomethacin is combined with dexamethasone.


The risk or severity of adverse effects can be increased when celecoxib is combined with etodolac.


The risk or severity of adverse effects can be increased when phenylephrine is combined with acebutolol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when clozapine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when celecoxib is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Melatonin.


The risk or severity of adverse effects can be increased when enalapril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when pentazocine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when dibucaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with trazodone.


The risk or severity of adverse effects can be increased when butabarbital is combined with estazolam.


The risk or severity of adverse effects can be increased when Efonidipine is combined with lovastatin.


The risk or severity of adverse effects can be increased when dopamine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when fluocinonide is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when clonidine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Trospium is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when temazepam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when amobarbital is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when losartan is combined with methyldopa.


The risk or severity of adverse effects can be increased when amitriptyline is combined with periciazine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with hydralazine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with dibucaine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when diazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when protriptyline is combined with selegiline.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with tiapride.


The risk or severity of adverse effects can be increased when clozapine is combined with pimozide.


The risk or severity of adverse effects can be increased when baclofen is combined with triprolidine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when baclofen is combined with methocarbamol.


The risk or severity of adverse effects can be increased when nadolol is combined with cilazapril.


The risk or severity of adverse effects can be increased when suprofen is combined with fenbufen.


The risk or severity of adverse effects can be increased when IDARUBICIN is combined with clozapine.


The risk or severity of adverse effects can be increased when temazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when suprofen is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with diflorasone.


The risk or severity of adverse effects can be increased when benazepril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when butamben is combined with felbamate.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with trandolapril.


The risk or severity of adverse effects can be increased when lisinopril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when LISURIDE is combined with mequitazine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with mecamylamine.


The risk or severity of adverse effects can be increased when clonazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with azelastine.


The risk or severity of adverse effects can be increased when gabapentin is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Retigabine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with METAXALONE.


The risk or severity of adverse effects can be increased when alprazolam is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when alprazolam is combined with Halazepam.


The risk or severity of adverse effects can be increased when Amfepramone is combined with selegiline.


The risk or severity of adverse effects can be increased when difluprednate is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when epirizole is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when thioridazine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ethotoin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with tretinoin.


The risk or severity of adverse effects can be increased when methadone is combined with enflurane.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when butamben is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when tretinoin is combined with spironolactone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when zopiclone is combined with bupivacaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when zopiclone is combined with Etomidate.


The risk or severity of adverse effects can be increased when irbesartan is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Spirapril.


The risk or severity of adverse effects can be increased when thioridazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when pergolide is combined with prednisone.


The risk or severity of adverse effects can be increased when pergolide is combined with astemizole.


The risk or severity of adverse effects can be increased when amphotericin b is combined with manidipine.


The risk or severity of adverse effects can be increased when reserpine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when fenoprofen is combined with haloperidol.


The risk or severity of adverse effects can be increased when reserpine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when aspirin is combined with alclometasone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with cilnidipine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Efonidipine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Ifenprodil is combined with Olsalazine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with vinorelbine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with clozapine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when demeclocycline is combined with Bexarotene.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with retinol.


The risk or severity of adverse effects can be increased when nicergoline is combined with Luliconazole.


The risk or severity of adverse effects can be increased when chlormezanone is combined with triprolidine.


The risk or severity of adverse effects can be increased when Articaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when chlormezanone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Olopatadine is combined with citalopram.


The risk or severity of adverse effects can be increased when selegiline is combined with procarbazine.


The risk or severity of adverse effects can be increased when sulpiride is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when selegiline is combined with terazosin.


The risk or severity of adverse effects can be increased when sulpiride is combined with chlormezanone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when butorphanol is combined with trazodone.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Remoxipride is combined with fexofenadine.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when midodrine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Bretylium.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Iloperidone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with bleomycin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with chlorambucil.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with nilvadipine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Raltitrexed.


The risk or severity of adverse effects can be increased when nefazodone is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Melatonin is combined with Flibanserin.


The risk or severity of adverse effects can be increased when prazosin is combined with Riociguat.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with tolmetin.


The risk or severity of adverse effects can be increased when thiamylal is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with haloperidol.


The risk or severity of adverse effects can be increased when sulpiride is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when trazodone is combined with naratriptan.


The risk or severity of adverse effects can be increased when trazodone is combined with rizatriptan.


The risk or severity of adverse effects can be increased when trazodone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Tramadol is combined with dantrolene.


The risk or severity of adverse effects can be increased when benazepril is combined with nifedipine.


The risk or severity of adverse effects can be increased when thalidomide is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Bevantolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with triprolidine.


The risk or severity of adverse effects can be increased when promazine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Pirlindole is combined with terbutaline.


The risk or severity of adverse effects can be increased when Tolcapone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Retigabine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with dimethyl sulfoxide.


The risk or severity of adverse effects can be increased when Etomidate is combined with Halazepam.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Normethadone.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when salicylic acid is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when aspirin is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Melatonin is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with butalbital.


The risk or severity of adverse effects can be increased when aspirin is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when isradipine is combined with felodipine.


The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Pizotifen.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when chlormezanone is combined with amisulpride.


The risk or severity of adverse effects can be increased when flunarizine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with carvedilol.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when ethotoin is combined with doxepin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Sorafenib.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when enalapril is combined with suprofen.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Fospropofol.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with levorphanol.


The risk or severity of adverse effects can be increased when Arotinolol is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with methylergonovine.


The risk or severity of adverse effects can be increased when oxycodone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Quinine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when diazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with ethotoin.


The risk or severity of adverse effects can be increased when apomorphine is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when diazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when imipramine is combined with Riociguat.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Torasemide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with clindamycin.


The risk or severity of adverse effects can be increased when losartan is combined with apraclonidine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with danazol.


The risk or severity of adverse effects can be increased when haloperidol is combined with bromazepam.


The risk or severity of adverse effects can be increased when methadone is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with butamben.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when benzphetamine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Tixocortol.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with xylometazoline.


The risk or severity of adverse effects can be increased when meprobamate is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with levodopa.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with etizolam.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with sotalol.


The risk or severity of adverse effects can be increased when olanzapine is combined with scopolamine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with rapamycin.


The risk or severity of adverse effects can be increased when Apremilast is combined with estrone.


The risk or severity of adverse effects can be increased when tenoxicam is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with buspirone.


The risk or severity of adverse effects can be increased when Articaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Lofexidine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Halazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when docetaxel is combined with cytarabine.


The risk or severity of adverse effects can be increased when eperisone is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when lorazepam is combined with sertraline.


The risk or severity of adverse effects can be increased when lorazepam is combined with pimozide.


The risk or severity of adverse effects can be increased when tetracaine is combined with citalopram.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Treprostinil is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when losartan is combined with nabumetone.


The risk or severity of adverse effects can be increased when fenoprofen is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when losartan is combined with ketorolac.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when tiagabine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Pipamperone is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Pipamperone is combined with doxepin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when fenoprofen is combined with amcinonide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Cariprazine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when doxorubicin is combined with leflunomide.


The risk or severity of adverse effects can be increased when zaleplon is combined with brotizolam.


The risk or severity of adverse effects can be increased when Paliperidone is combined with topiramate.


The risk or severity of adverse effects can be increased when proparacaine is combined with clidinium.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when pentazocine is combined with brotizolam.


The risk or severity of adverse effects can be increased when desoximetasone is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Masoprocol is combined with desoximetasone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with pipobroman.


The risk or severity of adverse effects can be increased when morphine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when morphine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when morphine is combined with nadolol.


The risk or severity of adverse effects can be increased when LISURIDE is combined with oxybutynin.


The risk or severity of adverse effects can be increased when promazine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when celecoxib is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when methoxamine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when clidinium is combined with nefazodone.


The risk or severity of adverse effects can be increased when levodopa is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when minoxidil is combined with spironolactone.


The risk or severity of adverse effects can be increased when ketoprofen is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when levodopa is combined with pargyline.


The risk or severity of adverse effects can be increased when benztropine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Ticagrelor is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Posaconazole is combined with oxycodone.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when pargyline is combined with linezolid.


The risk or severity of adverse effects can be increased when salicylic acid is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when butorphanol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with modafinil.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with fenbufen.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Mometasone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with colchicine.


The risk or severity of adverse effects can be increased when etizolam is combined with paroxetine.


The risk or severity of adverse effects can be increased when phenytoin is combined with METAXALONE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when butalbital is combined with vigabatrin.


The risk or severity of adverse effects can be increased when procarbazine is combined with Isometheptene.


The risk or severity of adverse effects can be increased when loxapine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when lisinopril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when clozapine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when codeine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Amrinone is combined with fluvastatin.


The risk or severity of adverse effects can be increased when codeine is combined with ondansetron.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Amrinone is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when benztropine is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when codeine is combined with zonisamide.


The risk or severity of adverse effects can be increased when lisinopril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Eletriptan is combined with amitriptyline.


The risk or severity of adverse effects can be increased when duloxetine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Butethal.


The risk or severity of adverse effects can be increased when rasagiline is combined with promazine.


The risk or severity of adverse effects can be increased when rasagiline is combined with spironolactone.


The risk or severity of adverse effects can be increased when Butethal is combined with levodopa.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with droperidol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with flunarizine.


The risk or severity of adverse effects can be increased when Etomidate is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when thiothixene is combined with clonazepam.


The risk or severity of adverse effects can be increased when thiothixene is combined with promethazine.


The risk or severity of adverse effects can be increased when metolazone is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when butabarbital is combined with Tolcapone.


The risk or severity of adverse effects can be increased when thiothixene is combined with Melatonin.


The risk or severity of adverse effects can be increased when pramipexole is combined with irbesartan.


The risk or severity of adverse effects can be increased when pramipexole is combined with felodipine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Desloratadine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with penbutolol.


The risk or severity of adverse effects can be increased when Asenapine is combined with topiramate.


The risk or severity of adverse effects can be increased when procarbazine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with alclofenac.


The risk or severity of adverse effects can be increased when Articaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when Butethal is combined with oxprenolol.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when ramipril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when D-mannitol is combined with penbutolol.


The risk or severity of adverse effects can be increased when quetiapine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with tiapride.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when risperidone is combined with estazolam.


The risk or severity of adverse effects can be increased when imipramine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when diclofenac is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Glubionate calcium is combined with Paricalcitol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with antipyrine.


The risk or severity of adverse effects can be increased when equilin is combined with norfloxacin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with tetracaine.


The risk or severity of adverse effects can be increased when dyclonine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with terazosin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when clomipramine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with zotepine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when pramipexole is combined with acebutolol.


The risk or severity of adverse effects can be increased when Torasemide is combined with metoprolol.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Miltefosine is combined with xylometazoline.


The risk or severity of adverse effects can be increased when nortriptyline is combined with moclobemide.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Varenicline is combined with nicotine.


The risk or severity of adverse effects can be increased when Normethadone is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Iloperidone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with papaverine.


The risk or severity of adverse effects can be increased when cocaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when indinavir is combined with meperidine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when phenytoin is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with codeine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with fleroxacin.


The risk or severity of adverse effects can be increased when brotizolam is combined with etizolam.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Articaine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with clomipramine.


The risk or severity of adverse effects can be increased when Asenapine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Asenapine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Asenapine is combined with prazepam.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with paroxetine.


The risk or severity of adverse effects can be increased when risperidone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when risperidone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when irbesartan is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when risperidone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with fluocinonide.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when Asenapine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when butorphanol is combined with propofol.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Asenapine is combined with baclofen.


The risk or severity of adverse effects can be increased when prednisone is combined with enoxacin.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Droxicam.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with cilazapril.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when triprolidine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when clopidogrel is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Etidocaine.


The risk or severity of adverse effects can be increased when dibucaine is combined with levodopa.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when oxycodone is combined with loratadine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Bevantolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Bevantolol is combined with nicotine.


The risk or severity of adverse effects can be increased when dibucaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when nimesulide is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when nimesulide is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when reserpine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with clidinium.


The risk or severity of adverse effects can be increased when carprofen is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when dibucaine is combined with procaine.


The risk or severity of adverse effects can be increased when dibucaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with zonisamide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with cocaine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with tiagabine.


The risk or severity of adverse effects can be increased when Nabilone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with ondansetron.


The risk or severity of adverse effects can be increased when Nabilone is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when proparacaine is combined with Articaine.


The risk or severity of adverse effects can be increased when quazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when diclofenac is combined with etodolac.


The risk or severity of adverse effects can be increased when ondansetron is combined with ethotoin.


The risk or severity of adverse effects can be increased when diclofenac is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Dexrazoxane.


The risk or severity of adverse effects can be increased when diclofenac is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when phentolamine is combined with bumetanide.


The risk or severity of adverse effects can be increased when apomorphine is combined with pramipexole.


The risk or severity of adverse effects can be increased when risperidone is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Icatibant is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when risperidone is combined with dyclonine.


The risk or severity of adverse effects can be increased when zotepine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Valrubicin.


The risk or severity of adverse effects can be increased when benazepril is combined with Droxicam.


The risk or severity of adverse effects can be increased when Asenapine is combined with Articaine.


The risk or severity of adverse effects can be increased when tioconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when Atazanavir is combined with oxycodone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Difenoxin is combined with flunarizine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when thiopental is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when perphenazine is combined with zaleplon.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Eprosartan.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with bumetanide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with quinapril.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with quinapril.


The risk or severity of adverse effects can be increased when tofisopam is combined with atorvastatin.


The risk or severity of adverse effects can be increased when dyclonine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when trandolapril is combined with nifedipine.


The risk or severity of adverse effects can be increased when Metixene is combined with methadone.


The risk or severity of adverse effects can be increased when secobarbital is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when risperidone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when dexamethasone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when floctafenine is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when dibucaine is combined with baclofen.


The risk or severity of adverse effects can be increased when secobarbital is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when floctafenine is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when benazepril is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when quetiapine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Trospium is combined with Mirabegron.


The risk or severity of adverse effects can be increased when ethosuximide is combined with METAXALONE.


The risk or severity of adverse effects can be increased when zotepine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when meclizine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when pimozide is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when midazolam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with triamterene.


The risk or severity of adverse effects can be increased when pentazocine is combined with promethazine.


The risk or severity of adverse effects can be increased when oxazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with nifedipine.


The risk or severity of adverse effects can be increased when oxazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when trandolapril is combined with furosemide.


The risk or severity of adverse effects can be increased when propoxyphene is combined with HEROIN.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Droxicam is combined with DESONIDE.


The risk or severity of adverse effects can be increased when carisoprodol is combined with duloxetine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Butethal.


The risk or severity of adverse effects can be increased when carbamazepine is combined with amobarbital.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when trimeprazine is combined with Vilazodone.


The risk or severity of adverse effects can be increased when levorphanol is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when bupivacaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when oxazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when valsartan is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when Agomelatine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Nabilone is combined with papaverine.


The risk or severity of adverse effects can be increased when alclometasone is combined with donepezil.


The risk or severity of adverse effects can be increased when triazolam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when flurazepam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Salsalate is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Butethal is combined with Desloratadine.


The risk or severity of adverse effects can be increased when triazolam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when gabapentin is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Nabilone is combined with nifedipine.


The risk or severity of adverse effects can be increased when flurazepam is combined with cocaine.


The risk or severity of adverse effects can be increased when moclobemide is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when dipyridamole is combined with Regadenoson.


The risk or severity of adverse effects can be increased when benztropine is combined with levorphanol.


The risk or severity of adverse effects can be increased when nystatin is combined with flunarizine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with betaxolol.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Agomelatine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with selegiline.


The risk or severity of adverse effects can be increased when epirizole is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Torasemide is combined with nadolol.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with IMIQUIMOD.


The risk or severity of adverse effects can be increased when pentazocine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Risedronic acid is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with dyclonine.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with oxycodone.


The risk or severity of adverse effects can be increased when Halazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when indapamide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when fenbufen is combined with Deferasirox.


The risk or severity of adverse effects can be increased when codeine is combined with butalbital.


The risk or severity of adverse effects can be increased when indapamide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when bromazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when tioconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with desoximetasone.


The risk or severity of adverse effects can be increased when methadone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when chloroquine is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Nebivolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Sacubitril is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Spirapril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when selegiline is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when selegiline is combined with rasagiline.


The risk or severity of adverse effects can be increased when halothane is combined with Etidocaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Nabilone is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when prazosin is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when nicergoline is combined with rapamycin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when clorazepate is combined with levorphanol.


The risk or severity of adverse effects can be increased when amoxapine is combined with zonisamide.


The risk or severity of adverse effects can be increased when ramipril is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when amoxapine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with salicylamide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with bumetanide.


The risk or severity of adverse effects can be increased when reserpine is combined with estazolam.


The risk or severity of adverse effects can be increased when spironolactone is combined with dipyridamole.


The risk or severity of adverse effects can be increased when clozapine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when isoflurane is combined with amitriptyline.


The risk or severity of adverse effects can be increased when clozapine is combined with dibucaine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Tolcapone.


The risk or severity of adverse effects can be increased when isoflurane is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when Pirlindole is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when propofol is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when cabergoline is combined with promazine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with dantrolene.


The risk or severity of adverse effects can be increased when Olopatadine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when midodrine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when Calcium phosphate is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with phenytoin.


The risk or severity of adverse effects can be increased when ipratropium is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when butorphanol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when quinapril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when alclofenac is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when tolmetin is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when phenobarbital is combined with benzocaine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with vigabatrin.


The risk or severity of adverse effects can be increased when piracetam is combined with Liotrix.


The risk or severity of adverse effects can be increased when risperidone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when mecamylamine is combined with tizanidine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with vigabatrin.


The risk or severity of adverse effects can be increased when secobarbital is combined with lithium ion.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Eplerenone is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with topiramate.


The risk or severity of adverse effects can be increased when etodolac is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when bromazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when etodolac is combined with Halobetasol.


The risk or severity of adverse effects can be increased when bromazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when flurazepam is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when flurazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when metaraminol is combined with dobutamine.


The risk or severity of adverse effects can be increased when buspirone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when flurazepam is combined with benzocaine.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with mefloquine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with D-mannitol.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with nortriptyline.


The risk or severity of adverse effects can be increased when buspirone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Valganciclovir is combined with Entecavir.


The risk or severity of adverse effects can be increased when dyclonine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when secobarbital is combined with proparacaine.


The risk or severity of adverse effects can be increased when dyclonine is combined with flunarizine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when procarbazine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when ketamine is combined with ondansetron.


The risk or severity of adverse effects can be increased when ketamine is combined with tiagabine.


The risk or severity of adverse effects can be increased when ketamine is combined with cocaine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when ketamine is combined with zonisamide.


The risk or severity of adverse effects can be increased when diazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when buprenorphine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when flurazepam is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when barnidipine is combined with irbesartan.


The risk or severity of adverse effects can be increased when loratadine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when barnidipine is combined with felodipine.


The risk or severity of adverse effects can be increased when barnidipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when isradipine is combined with timolol.


The risk or severity of adverse effects can be increased when amprenavir is combined with meperidine.


The risk or severity of adverse effects can be increased when clonazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when venlafaxine is combined with sulpiride.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with scopolamine.


The risk or severity of adverse effects can be increased when selegiline is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Tolcapone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with propoxyphene.


The risk or severity of adverse effects can be increased when nalbuphine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when prazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Ivacaftor.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with zaleplon.


The risk or severity of adverse effects can be increased when desipramine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Melatonin.


The risk or severity of adverse effects can be increased when niflumic acid is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when amobarbital is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when triflupromazine is combined with promethazine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with clonazepam.


The risk or severity of adverse effects can be increased when brotizolam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when phenytoin is combined with methocarbamol.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with fluocinonide.


The risk or severity of adverse effects can be increased when pentobarbital is combined with meclizine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with topiramate.


The risk or severity of adverse effects can be increased when perphenazine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when benzocaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with nadolol.


The risk or severity of adverse effects can be increased when thalidomide is combined with Riociguat.


The risk or severity of adverse effects can be increased when biperiden is combined with oxymorphone.


The risk or severity of adverse effects can be increased when gabapentin is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when gabapentin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when biperiden is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with carprofen.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with ethotoin.


The risk or severity of adverse effects can be increased when butorphanol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Apremilast is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Pinaverium.


The risk or severity of adverse effects can be increased when diclofenac is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when ketorolac is combined with estrone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Apremilast is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when halothane is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when Rotigotine is combined with minoxidil.


The risk or severity of adverse effects can be increased when tizanidine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when halothane is combined with metolazone.


The risk or severity of adverse effects can be increased when halothane is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with meclizine.


The risk or severity of adverse effects can be increased when formestane is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when etodolac is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Tramadol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when butalbital is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Flupentixol is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Naftifine is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Naftifine is combined with Tixocortol.


The risk or severity of adverse effects can be increased when butamben is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with manidipine.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with Benidipine.


The risk or severity of adverse effects can be increased when isradipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with pramipexole.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when isoflurane is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when quinapril is combined with quetiapine.


The risk or severity of adverse effects can be increased when isradipine is combined with irbesartan.


The risk or severity of adverse effects can be increased when triazolam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when triazolam is combined with ondansetron.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Riociguat.


The risk or severity of adverse effects can be increased when propofol is combined with Articaine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Normethadone.


The risk or severity of adverse effects can be increased when Artemether is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when MELPERONE is combined with dantrolene.


The risk or severity of adverse effects can be increased when thiothixene is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Halazepam is combined with cocaine.


The risk or severity of adverse effects can be increased when Halazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when Halazepam is combined with ondansetron.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Halazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with quetiapine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with oxprenolol.


The risk or severity of adverse effects can be increased when ropinirole is combined with furosemide.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Rufinamide is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Rufinamide is combined with prazepam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with quazepam.


The risk or severity of adverse effects can be increased when Apremilast is combined with Icatibant.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with ketoprofen.


The risk or severity of adverse effects can be increased when nitric oxide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with paramethasone.


The risk or severity of adverse effects can be increased when benazepril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when oxazepam is combined with Halazepam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with loratadine.


The risk or severity of adverse effects can be increased when meperidine is combined with doxepin.


The risk or severity of adverse effects can be increased when oxazepam is combined with proparacaine.


The risk or severity of adverse effects can be increased when tolmetin is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with baclofen.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Etomidate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with lorazepam.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with imipramine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with quinapril.


The risk or severity of adverse effects can be increased when meprobamate is combined with primidone.


The risk or severity of adverse effects can be increased when tacrolimus is combined with vincristine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Bretylium.


The risk or severity of adverse effects can be increased when tacrolimus is combined with 5-Fluorouracil.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when topiramate is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when barnidipine is combined with tizanidine.


The risk or severity of adverse effects can be increased when bepridil is combined with spironolactone.


The risk or severity of adverse effects can be increased when fenoprofen is combined with alclofenac.


The risk or severity of adverse effects can be increased when cabergoline is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when topiramate is combined with amoxapine.


The risk or severity of adverse effects can be increased when clozapine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when methysergide is combined with Linagliptin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with felbamate.


The risk or severity of adverse effects can be increased when cabergoline is combined with sulfinpyrazone.


The risk or severity of adverse effects can be increased when thioridazine is combined with tetracaine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when ropinirole is combined with Eprosartan.


The risk or severity of adverse effects can be increased when thiamylal is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when procarbazine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Propiverine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with brotizolam.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when chloroquine is combined with Mometasone.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Propiverine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with zonisamide.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with tiagabine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with ondansetron.


The risk or severity of adverse effects can be increased when Ibandronic Acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when morphine is combined with spironolactone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with cisapride.


The risk or severity of adverse effects can be increased when morphine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Articaine.


The risk or severity of adverse effects can be increased when morphine is combined with triprolidine.


The risk or severity of adverse effects can be increased when Limaprost is combined with phenindione.


The risk or severity of adverse effects can be increased when nimesulide is combined with dexamethasone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with flunarizine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with methazolamide.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when nimesulide is combined with flunisolide.


The risk or severity of adverse effects can be increased when fenoprofen is combined with acemetacin.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when baclofen is combined with sertraline.


The risk or severity of adverse effects can be increased when pentamidine is combined with manidipine.


The risk or severity of adverse effects can be increased when zonisamide is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with loxapine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with triamterene.


The risk or severity of adverse effects can be increased when pentobarbital is combined with tiapride.


The risk or severity of adverse effects can be increased when tetracaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when quazepam is combined with lithium ion.


The risk or severity of adverse effects can be increased when quazepam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when quazepam is combined with Butethal.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with betaxolol.


The risk or severity of adverse effects can be increased when tizanidine is combined with Riociguat.


The risk or severity of adverse effects can be increased when meprobamate is combined with butalbital.


The risk or severity of adverse effects can be increased when amitriptyline is combined with selegiline.


The risk or severity of adverse effects can be increased when carprofen is combined with nimesulide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Propacetamol is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with pramipexole.


The risk or severity of adverse effects can be increased when rapamycin is combined with diltiazem.


The risk or severity of adverse effects can be increased when Ifenprodil is combined with salicylic acid.